A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood
Clinical trial NCT07081932 · COMPLETED
Trial details
- NCT number
- NCT07081932
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-26
- Primary completion
- 2025-09-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.